GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 82 filers reported holding GENERATION BIO CO in Q2 2023. The put-call ratio across all filers is 5.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,826 | – | 332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trustees of Columbia University in the City of New York | 312,876 | $8,870,000 | 11.85% |
| Foresite Capital Management IV, LLC | 857,939 | $24,323,000 | 2.64% |
| Artal Group S.A. | 2,814,191 | $79,782,000 | 1.71% |
| Darwin Global Management, Ltd. | 197,191 | $5,590,000 | 1.56% |
| Casdin Capital, LLC | 1,611,214 | $45,678,000 | 1.35% |
| Penn Mutual Asset Management | 40,545 | $1,149,000 | 1.02% |
| HARVARD MANAGEMENT CO INC | 521,460 | $14,783,000 | 0.80% |
| Bellevue Group AG | 2,333,180 | $66,146,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 961,215 | $27,250,000 | 0.54% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,268,819 | $64,321,000 | 0.39% |